1,764 results on '"Klastersky, Jean A."'
Search Results
2. A prospective, real-world, multinational study of febrile neutropenia (FN) occurrence in oncology patients receiving chemotherapy with intermediate risk of FN: a MASCC Neutropenia, Infection, and Myelosuppression Study Group initiative
3. Editorial: Advanced care planning
4. Editorial: Psychological interventions in oncology: advances and challenges
5. Infections and Cancer
6. The conquest of lung cancer in Central Europe
7. Photobiomodulation therapy in management of cancer therapy-induced side effects
8. Development of the Multi-Dimensional Analysis of Patient Outcome Predictions (MD.POP) during medical encounters
9. Supportive care: do we need a model?
10. Use of granulocyte-colony stimulating factors in older patients: a review of recently published data
11. Impact of chemotherapy-induced neutropenia (CIN) and febrile neutropenia (FN) on cancer treatment outcomes: An overview about well-established and recently emerging clinical data
12. Prediction of the Risk of Complications Associated with Febrile Neutropenia
13. At the Extremes of Age: Febrile Neutropenia in Children and Elderly
14. Costs Associated with Febrile Neutropenia
15. Management of Persistent Fever in Patients with Neutropenia Despite Empirical Antibiotic Administration
16. Introduction
17. Management of the Non-low-Risk Patients with Febrile Neutropenia
18. Prevention of Febrile Neutropenia
19. Predictors of physicians’ communication performance in a decision-making encounter with a simulated advanced-stage cancer patient: A longitudinal study
20. Editorial: Supportive care: do we need a model?
21. The close interrelation between colorectal cancer, infection and microbiota
22. Editorial: Supportive care in cancer patients: a constantly evolving field
23. Editorial introductions
24. Supportive care for patients undergoing immunotherapy
25. Strategies for the empirical management of infection in cancer patients with emphasis on the emergence of resistant gram-negative bacteria
26. Therapy of Febrile Neutropenia: An Algorithm for Current Clinical Attitudes Taking into Account Cost Benefit
27. The concept of oligometastases in colorectal cancer: from the clinical evidences to new therapeutic strategies
28. Supportive care in cancer: quo vadis
29. Supportive care in the era of immunotherapies for advanced non-small-cell lung cancer
30. Febrile neutropenia (FN) occurrence outside of clinical trials: occurrence and predictive factors in adult patients treated with chemotherapy and an expected moderate FN risk. Rationale and design of a real-world prospective, observational, multinational study
31. The emerging problem of bacterial resistance in cancer patients; proceedings of a workshop held by MASCC “Neutropenia, Infection and Myelosuppression” Study Group during the MASCC annual meeting held in Berlin on 27–29 June 2013
32. Supportive/palliative care in cancer patients: quo vadis?
33. Empiric therapy for bacterial infections in neutropenic patients
34. The conquest of lung cancer in Central Europe
35. Interventions in psuycho-oncology
36. Recent findings and future challenges for psychological interventions in the field of oncology
37. Concurrent driver mutations/rearrangements in non-small-cell lung cancer
38. Milestones in the use of chemotherapy for the management of non-small cell lung cancer (NSCLC)
39. Understanding the risk for infection in patients with neutropenia
40. Febrile neutropenia: A critical review of the initial management
41. Prevention of febrile neutropenia in chemotherapy-treated cancer patients: Pegylated versus standard myeloid colony stimulating factors. Do we have a choice?
42. The conquest of lung cancer in Central Europe
43. Prophylaxis of febrile neutropenia in adults receiving chemotherapy needs to be adapted to the risk
44. The Multinational Association for Supportive Care in Cancer (MASCC) risk index score: 10 years of use for identifying low-risk febrile neutropenic cancer patients
45. Febrile Neutropenia
46. Editorial introductions
47. Editorial: Supportive care in cancer patients: quo vadis?
48. Predicting febrile neutropenic patients at low risk using the MASCC score: does bacteremia matter?
49. Insight on Variables Leading to Burnout in Cancer Physicians
50. Editorial: Supportive care in cancer patients: quo vadis?
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.